Largest Hong Kong (HSI) Pharmaceuticals & Biotech Stocks by Market Cap

UPDATED Jul 08, 2024

Discover large cap Hong Kong Pharmaceuticals & Biotech companies that are on the HSI. These Pharmaceuticals & Biotech Companies are organised by Market Cap.

102 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

3692

Hansoh Pharmaceutical Group
HK$15.82-3.1%25.0%HK$93.7bHK$19.51PE26.6xE8.8%1.8%

1093

CSPC Pharmaceutical Group
HK$6.09-2.1%-6.6%HK$71.9bHK$9.58PE11xE4.5%4.5%

1801

Innovent Biologics
HK$37.802.7%27.1%HK$61.5bHK$55.80PS9.2xE50.8%n/a

1177

Sino Biopharmaceutical
HK$2.794.5%-18.7%HK$51.2bHK$4.59PE25.8xE13.7%1.8%

2269

WuXi Biologics (Cayman)
HK$10.78-6.6%-71.6%HK$44.8bHK$22.62PE12.3xE13.7%n/a

3320

China Resources Pharmaceutical Group
HK$5.58-3.6%-10.4%HK$35.1bHK$7.38PE8.5xE7.1%3.0%

6990

Sichuan Kelun-Biotech Biopharmaceutical
HK$147.00-11.3%n/aHK$32.8bHK$201.36PS19.8xE31.2%n/a

9926

Akeso
HK$36.65-2.9%2.8%HK$31.7bHK$59.29PE14.6xE8.5%n/a

1877

Shanghai Junshi Biosciences
HK$12.264.8%-46.6%HK$27.2bHK$17.30PS6.9xE26.2%n/a

1548

Genscript Biotech
HK$8.846.3%-46.1%HK$18.8bHK$25.03PS2.9xE97.9%0%

2228

QuantumPharm
HK$5.371.7%n/aHK$18.3bn/aPS97.6xn/an/a

2268

WuXi XDC Cayman
HK$15.16-12.4%n/aHK$18.2bHK$30.95PE59.6xE44.6%n/a

570

China Traditional Chinese Medicine Holdings
HK$3.52-3.0%2.3%HK$17.7bHK$4.93PE12.8xE10.5%0%

9995

RemeGen
HK$17.56-28.3%-51.5%HK$17.0bHK$39.94PS7.1xE54.9%n/a

512

Grand Pharmaceutical Group
HK$4.721.5%8.8%HK$16.5bn/aPE8.8xE13.9%5.5%

867

China Medical System Holdings
HK$6.31-4.7%-47.1%HK$15.4bHK$10.85PE6xE6.8%6.7%

1530

3SBio
HK$6.30-2.2%-12.3%HK$14.8bHK$7.56PE8.9xE12.6%3.9%

3933

United Laboratories International Holdings
HK$8.06-2.2%37.1%HK$14.6bHK$12.28PE5xE1.7%7.1%

2096

Simcere Pharmaceutical Group
HK$5.53-3.5%-26.4%HK$14.0bHK$8.52PE18.2xE23.7%3.2%

6826

Shanghai Haohai Biological Technology
HK$33.003.8%43.5%HK$13.3bn/aPE16.7xE18.2%1.7%

2005

SSY Group
HK$4.301.9%-6.3%HK$12.8bHK$6.23PE9.7xE15.0%4.0%

2696

Shanghai Henlius Biotech
HK$22.850%79.6%HK$12.4bHK$20.22PE21.2xE15.8%n/a

6600

SciClone Pharmaceuticals (Holdings)
HK$18.720%78.3%HK$11.4bHK$15.64PE9.4xE4.1%0%

2186

Luye Pharma Group
HK$2.907.4%-17.8%HK$10.9bHK$3.05PE19.1xE26.8%0%
Page 1 of 5
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.